238 related articles for article (PubMed ID: 26124775)
1. Prevalence of hepatitis B and C and relationship to liver damage in HIV infected patients attending Joint Clinical Research Centre Clinic (JCRC), Kampala, Uganda.
Baseke J; Musenero M; Mayanja-Kizza H
Afr Health Sci; 2015 Jun; 15(2):322-7. PubMed ID: 26124775
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
4. HIV Co-Infection with Hepatitis B and C and Liver Function in Children and Adolescents on Antiretroviral Therapy in a Tertiary Health Institution in Abuja.
Okechukwu AA; Thairu Y; Dalili MS
West Afr J Med; 2020; 37(3):260-267. PubMed ID: 32476120
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya.
Muriuki BM; Gicheru MM; Wachira D; Nyamache AK; Khamadi SA
BMC Res Notes; 2013 Sep; 6():363. PubMed ID: 24016453
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.
Chandra N; Joshi N; Raju YS; Kumar A; Teja VD
Indian J Med Res; 2013 Dec; 138(6):950-4. PubMed ID: 24521641
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
14. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina.
Pereson MJ; MartÃnez AP; Isaac K; Laham G; Ridruejo E; Garcia GH; Flichman DM; Di Lello FA
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33180017
[No Abstract] [Full Text] [Related]
17. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]